PCV89 - Economic Evaluation of ASA 100mg, Simvastatin 40mg and Ramipril 5-10mg (POLYPILL) for Secondary Prevention of Cardiovascular Events in Mexico
| Autor: | Kaskens, L, Gracia, A, Rodriguez Mendoza, M, Escobar Juárez, Y, Mendoza Medrano, G, Soto Molina, H |
|---|---|
| Zdroj: | In Value in Health November 2016 19(7):A652-A652 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect